Cedara Software Unveils B-CAD(TM) at RSNA 2004 - A Major Breakthrough in Breast Ultrasound Computer Assisted Detection

Share Name	Share Symbol	Market	Type
Cedara Software Corp (MM)	NASDAQ:CDSW	NASDAQ	Common Stock

Cedara (NASDAQ:CDSW)
Historical Stock Chart

From Jun 2019 to Jun 2024

Cedara Software Unveils B-CAD(TM) at RSNA 2004 - A Major Breakthrough in Breast Ultrasound Computer Assisted Detection - Has the potential to become a new standard of care in Women's Health by greatly assisting Radiologists in diagnosing breast cancer and thereby reducing the need for painful and expensive biopsies - Can be deployed in Cedara's Multi-Modality CAD Workstation for Breast Imaging giving seamless access to all forms of breast image data and CAD technology TORONTO, Nov. 28 /PRNewswire-FirstCall/ -- Cedara Software Corp. (NASDAQ:CDSW/TSX:CDE), recently named Fastest Growing Healthcare Company for 2004 by America's foremost market research firm Frost and Sullivan, today unveiled its Cedara B-CAD(TM) technology, a ground-breaking innovation in breast ultrasound. B-CAD is designed to perform Computer Aided Detection and Diagnosis. B-CAD uses a sophisticated image analysis scheme to determine over 20 sonographic lesion characteristics, and an advanced decision engine to help identify benign and malignant lesions. Based on the pioneering 1995 study on solid breast nodules by Dr. A. Thomas Stavros et al, and reviewed by Dr. Stavros using an immense database of biopsy-correlated breast ultrasound data, B-CAD can provide the radiologist with CAD information on the clinically relevant characteristics and features of the target of interest as well as the probability that a target lesion is either benign or malignant. B-CAD has the potential to reduce operator variability in breast ultrasound and provide the Radiologist with valuable insight when determining the correct BI-RADS category for a lesion. B-CAD can be seamlessly integrated with PACS and Mammography workflows, and can be used in conjunction with live ultrasound through video acquisition solutions such as DICOMIT Information Manager(TM) or Cedara I-AcquireVideo(TM). B-CAD is available to OEMs for integration with imaging systems, or inclusion in next-generation ultrasound equipment. B-CAD provides ultrasonographers with a new tool in the diagnosis of breast cancer, can promote the greater adoption of breast ultrasound, and will be a catalyst for the emergence of routine breast cancer screening using ultrasound. "The combination of B-CAD with Cedara's multi-modality CAD workstation is a phenomenal step forward for breast imaging" stated Jeff Collins, CEO of Medipattern Corporation - Cedara's partner in breast imaging and pioneer of the B-CAD technology, "The combination of CAD systems for Mammography, MRI and Ultrasound in one streamlined package is an industry first, and makes Cedara's I-ReadMammo the preeminent solution for breast imaging." Cedara I-ReadMammo provides unprecedented viewing capabilities for Mammography and multi-modality breast data, and works with all the major brands of imaging equipment. The inclusion of B-CAD completes its roster of CAD solutions for mainstream breast imaging modalities, and makes the concept of a multi-modality CAD workstation for breast imaging a reality. "B-CAD is the first ultrasound CAD to be demonstrated at RSNA and is an amazing technology that can benefit women worldwide," stated Chris Barlow, Cedara's Director of Business Development. "It is the most sophisticated and advanced system for breast ultrasound, and can change how breast cancer is found and diagnosed. B-CAD is available for immediate OEM integration, and we are working to find partners from all areas of breast ultrasound and oncology to help bring this hugely positive advancement to market." Cedara's B-CAD prototype can be seen in concert with Cedara I-ReadMammo at the 2004 Radiological Society of North America 90th Scientific Assembly and Annual Meeting (RSNA), held November 28 to December 3 in Chicago. B-CAD availability for clinical use is subject to regulatory clearance. For more information about Cedara's complete range of medical imaging products, visit the Cedara website at http://www.cedara.com/. Or contact: Jacques Cornet, Vice President of Marketing & Operations (905) 672-2100 ext. 2564 Email: For investor-related inquiries, contact: Brian Pedlar, Chief Financial Officer (905) 672-2100 ext. 2015 Email: About Cedara Software: Cedara Software Corp. is a leading independent provider of medical imaging technologies. Cedara software is deployed in hospitals and clinics worldwide and is licensed by many of the world's leading medical device and healthcare information technology companies. Approximately 28,000 medical imaging systems and 6,400 Picture Archiving and Communications System (PACS) workstations have been licensed to date. Cedara recently acquired eMed Technologies Corporation, widely known as a provider of innovative PACS and teleradiology solutions that have been installed in over 2,000 hospitals and imaging centers. Cedara is quite unique in that it has technologies and expertise that span all the major digital imaging modalities including computed tomography (CT), magnetic resonance imaging (MRI), digital X-ray, mammography, ultrasound, echo-cardiology, angiography, nuclear medicine, positron emission tomography (PET) and fluoroscopy. Furthermore, the Company's medical imaging offerings are used in all aspects of clinical workflow including the capture of a patient's digital image; the archiving, communication and manipulation of digital images; sophisticated clinical applications to analyze digital images; and even the use of imaging in minimally-invasive surgery. Certain statements contained in this news release are forward-looking within the meaning of securities laws and are based on current expectations that are subject to a number of assumptions, uncertainties and risks, and there are actual results may differ materially from what is currently expected. These assumptions, uncertainties and risks include, but are not limited to: the management of the growth of the Company, dependence on key personnel of the Company, competitive pressures (including price competition), changes in market activity, risks associated with international operations, the development of new products and services, the enhancement of existing products and services, the introduction of competing products having technological and/or other advantages, the dependence on key customers, regulatory changes to the health care industry, seasonality, economic and political conditions and adequate protection of the proprietary interests of the Company. Further information about these risks and uncertainties can be found in the continuous disclosure documents filed from time to time by Cedara with the securities regulatory authorities, which documents are available at http://www.sedar.com/. All trademarks appearing in this release are the property of Cedara Software Corp. DATASOURCE: Cedara Software Corp. CONTACT: Contact: Jacques Cornet, Vice President of Marketing & Operations, Cedara Software Corp., (905) 672-2100 ext. 2564, ; For investor-related inquiries, contact: Brian Pedlar, Chief Financial Officer, (905) 672-2100 ext. 2015, Email: ; To request a free copy of this organization's annual report, please go to http://www.newswire.ca/ and click on reports@cnw.

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

CDSW Cedara Software Corp (MM)